Literature DB >> 31325300

Development and validation of a concise scale for assessing patient experience of primary care for adults in Japan.

Takuya Aoki1, Shunichi Fukuhara1,2,3, Yosuke Yamamoto1.   

Abstract

BACKGROUND: The existing scales to measure patient experience of primary care for adults tend to be with many items and difficult to use outside of the research setting.
OBJECTIVE: To develop a Japanese version of Primary Care Assessment Tool Short Form as a concise scale for assessing patient experience of primary care and to examine its validity and reliability.
METHODS: We conducted a cross-sectional survey in a primary care practice-based research network in Japan (25 primary care facilities). We evaluated the structural validity, criterion-related validity, convergent validity and the internal consistency reliability of the scale.
RESULTS: Data were analysed for 1725 primary care outpatients. A 13-item scale was constructed, and the confirmatory factor analysis showed excellent goodness of fit of the six-factor model (first contact, longitudinality, coordination, comprehensiveness (services available), comprehensiveness (services provided) and community orientation). Pearson correlation coefficients between the total score and the overall rating of care and the original scale total score were 0.43 and 0.94, respectively. The total score was positively associated with influenza and pneumococcal vaccination (P < 0.001; P = 0.009 for trend). All of the multi-item scales achieved good internal consistency and the overall Cronbach's alpha was 0.77.
CONCLUSIONS: We developed a concise patient experience scale, which comprises six domains measuring primary care attributes and evaluated its validity and reliability. This scale can be used as a rapid assessment tool reducing the burden of respondents and provide effective information for further quality improvement and practice-based research in the Japanese primary care settings.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  family medicine; patient experience; patient-centred care; primary care assessment tool; primary health care; quality measurement

Mesh:

Year:  2020        PMID: 31325300     DOI: 10.1093/fampra/cmz038

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  6 in total

1.  Development and validation of a Japanese version of the person-centered primary care measure.

Authors:  Makoto Kaneko; Tadao Okada; Takuya Aoki; Machiko Inoue; Takamasa Watanabe; Makoto Kuroki; Daichi Hayashi; Masato Matsushima
Journal:  BMC Prim Care       Date:  2022-05-10

2.  Patient experience of residents with restricted primary care access during the COVID-19 pandemic.

Authors:  Takuya Aoki; Yasuki Fujinuma; Masato Matsushima
Journal:  Fam Med Community Health       Date:  2022-06

3.  Associations of primary care structures with polypharmacy and patient-reported indicators in patients with complex multimorbidity: a multicentre cross-sectional study in Japan.

Authors:  Takuya Aoki; Yasuki Fujinuma; Masato Matsushima
Journal:  BMJ Open       Date:  2022-01-07       Impact factor: 2.692

4.  Usual source of primary care and preventive care measures in the COVID-19 pandemic: a nationwide cross-sectional study in Japan.

Authors:  Takuya Aoki; Yasuki Fujinuma; Masato Matsushima
Journal:  BMJ Open       Date:  2022-03-16       Impact factor: 2.692

5.  A systematic literature review of patient self-assessment instruments concerning quality of primary care in multiprofessional clinics.

Authors:  Jérémy Derriennic; Patrice Nabbe; Marie Barais; Delphine Le Goff; Thomas Pourtau; Benjamin Penpennic; Jean-Yves Le Reste
Journal:  Fam Pract       Date:  2022-09-24       Impact factor: 2.290

6.  Multimorbidity and patient-reported diagnostic errors in the primary care setting: multicentre cross-sectional study in Japan.

Authors:  Takuya Aoki; Satoshi Watanuki
Journal:  BMJ Open       Date:  2020-08-20       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.